TONIX PHARMACEUTICALS

Transcripts Tonix Pharmaceuticals Nasdaq

Stocks

TNXP

US8902608624

Pharmaceuticals

End-of-day quote Nasdaq 05/02/2024			5-day change	1st Jan Change
0.3222 ^USD	-2.36%		+2.32%	-20.05%

09-08	Tonix Pharmaceuticals Holding Corp. Announces Appointment of Thomas Englese to Chief Commercial Officer, Effective September 8, 2026	CI
08-18	Tonix Pharmaceuticals Holding Corp. Announces Appointment of Seth Lederman as Interim Chief Medical Officer	CI

Transcripts

08-10	Tonix Pharmaceuticals Holding Corp., Q2 2026 Earnings Call, Aug 10, 2026
18/08/25	Tonix Pharmaceuticals Holding Corp. - Special Call

No results match your criteria

All News Broker Recommendations Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies

Filters

As early as today, start finding the best investment opportunities!

×